Imexpharm Corporation (HOSE:IMP)
50,100
+1,550 (3.19%)
At close: Oct 31, 2025
Imexpharm Revenue
Imexpharm had revenue of 573.55B VND in the quarter ending September 30, 2025, with 5.29% growth. This brings the company's revenue in the last twelve months to 2.45T, up 13.47% year-over-year. In the year 2024, Imexpharm had annual revenue of 2.21T with 10.59% growth.
Revenue (ttm)
2.45T
Revenue Growth
+13.47%
P/S Ratio
3.15
Revenue / Employee
1.68B
Employees
1,452
Market Cap
7.72T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.21T | 211.08B | 10.59% |
| Jan 1, 2024 | 1.99T | 350.33B | 21.31% |
| Dec 31, 2022 | 1.64T | 377.11B | 29.77% |
| Dec 31, 2021 | 1.27T | -102.83B | -7.51% |
| Dec 31, 2020 | 1.37T | -33.03B | -2.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vingroup JSC | 255.48T |
| Hoa Phat Group JSC | 141.98T |
| Vinhomes JSC | 100.46T |
| Joint Stock Commercial Bank for Foreign Trade of Vietnam | 67.89T |
| FPT Corporation | 67.50T |
| Joint Stock Commercial Bank for Investment and Development of Vietnam | 61.61T |
| Vietnam Joint Stock Commercial Bank for Industry and Trade | 60.81T |
| Military Commercial Joint Stock Bank | 48.78T |